Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2017

01-09-2017 | Guide Line

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML)

Author: Shuichi Miyawaki

Published in: International Journal of Hematology | Issue 3/2017

Login to get access

Excerpt

Acute myeloid leukemia (AML) is a highly diverse hematologic malignancy characterized by autonomous clonal proliferation of immature myeloid cells that are unable to differentiate or mature normally. Abnormal proliferation of leukemic cells in the bone marrow markedly impairs normal hematopoiesis, causing various symptoms associated with leukopenia, anemia, and thrombocytopenia. It is a serious disease that can lead to death from infection or hemorrhage in a short period of time if not treated properly. …
Metadata
Title
JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML)
Author
Shuichi Miyawaki
Publication date
01-09-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2303-4

Other articles of this Issue 3/2017

International Journal of Hematology 3/2017 Go to the issue

Progress in Hematology

DNA damage response and hematological malignancy

Progress in Hematology

The DNA damage response pathway in normal hematopoiesis and malignancies

Original Article

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study

Original Article

Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia

Original Article

Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis

Original Article

Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits